These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
615 related items for PubMed ID: 28614296
21. Treatment and prevention of urinary tract infection with orally active FimH inhibitors. Cusumano CK, Pinkner JS, Han Z, Greene SE, Ford BA, Crowley JR, Henderson JP, Janetka JW, Hultgren SJ. Sci Transl Med; 2011 Nov 16; 3(109):109ra115. PubMed ID: 22089451 [Abstract] [Full Text] [Related]
22. Antiadhesive natural products against uropathogenic E. coli: What can we learn from cranberry extract? Scharf B, Schmidt TJ, Rabbani S, Stork C, Dobrindt U, Sendker J, Ernst B, Hensel A. J Ethnopharmacol; 2020 Jul 15; 257():112889. PubMed ID: 32311481 [Abstract] [Full Text] [Related]
23. Functional role of the type 1 pilus rod structure in mediating host-pathogen interactions. Spaulding CN, Schreiber HL, Zheng W, Dodson KW, Hazen JE, Conover MS, Wang F, Svenmarker P, Luna-Rico A, Francetic O, Andersson M, Hultgren S, Egelman EH. Elife; 2018 Jan 18; 7():. PubMed ID: 29345620 [Abstract] [Full Text] [Related]
24. Design, synthesis and biological evaluation of mannosyl triazoles as FimH antagonists. Schwardt O, Rabbani S, Hartmann M, Abgottspon D, Wittwer M, Kleeb S, Zalewski A, Smieško M, Cutting B, Ernst B. Bioorg Med Chem; 2011 Nov 01; 19(21):6454-73. PubMed ID: 21962988 [Abstract] [Full Text] [Related]
27. A host receptor enables type 1 pilus-mediated pathogenesis of Escherichia coli pyelonephritis. McLellan LK, McAllaster MR, Kim AS, Tóthová Ľ, Olson PD, Pinkner JS, Daugherty AL, Hreha TN, Janetka JW, Fremont DH, Hultgren SJ, Virgin HW, Hunstad DA. PLoS Pathog; 2021 Jan 01; 17(1):e1009314. PubMed ID: 33513212 [Abstract] [Full Text] [Related]
28. Conformational ensembles in Klebsiella pneumoniae FimH impact uropathogenesis. Lopatto EDB, Pinkner JS, Sanick DA, Potter RF, Liu LX, Bazán Villicaña J, Tamadonfar KO, Ye Y, Zimmerman MI, Gualberto NC, Dodson KW, Janetka JW, Hunstad DA, Hultgren SJ. Proc Natl Acad Sci U S A; 2024 Sep 24; 121(39):e2409655121. PubMed ID: 39288182 [Abstract] [Full Text] [Related]
29. Structure-based discovery of glycomimetic FmlH ligands as inhibitors of bacterial adhesion during urinary tract infection. Kalas V, Hibbing ME, Maddirala AR, Chugani R, Pinkner JS, Mydock-McGrane LK, Conover MS, Janetka JW, Hultgren SJ. Proc Natl Acad Sci U S A; 2018 Mar 20; 115(12):E2819-E2828. PubMed ID: 29507247 [Abstract] [Full Text] [Related]
30. Compounds targeting YadC of uropathogenic Escherichia coli and its host receptor annexin A2 decrease bacterial colonization in bladder. Li X, Pei G, Zhang L, Cao Y, Wang J, Yu L, Dianjun W, Gao S, Zhang ZS, Yao Z, Wang Q. EBioMedicine; 2019 Dec 20; 50():23-33. PubMed ID: 31757778 [Abstract] [Full Text] [Related]
39. Genetic relatedness of the Escherichia coli fecal population and strains causing urinary tract infection in the same host. Bahadori M, Motamedifar M, Derakhshandeh A, Firouzi R, Motamedi Boroojeni A, Alinejad M, Naziri Z. Microbiologyopen; 2019 Jun 10; 8(6):e00759. PubMed ID: 30358940 [Abstract] [Full Text] [Related]
40. Synthesis and evaluation of thiomannosides, potent and orally active FimH inhibitors. Sattigeri JA, Garg M, Bhateja P, Soni A, Rauf ARA, Gupta M, Deshmukh MS, Jain T, Alekar N, Barman TK, Jha P, Chaira T, Bambal RB, Upadhyay DJ, Nishi T. Bioorg Med Chem Lett; 2018 Sep 15; 28(17):2993-2997. PubMed ID: 30017316 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]